Abstract
Background
An association between Schistosoma japonicum and colorectal cancer in humans has been known since a long time; however, this association remains understudied and lacks comprehensive experimentation support.
Objective
Various epidemiological and pathological studies have established the role of chronic inflammation as a major factor behind the induction of colorectal cancer. The aim of this review is to present the current knowledge on the association of Schistosoma japonicum with colorectal cancer.
Result
Mechanisms which lead to induction and progression of colorectal cancer are highlighted along with diagnosis and treatment for the same. Further, various methodologies, including mass drug administration, use of new drugs and vaccines, role of apoptosis, and histone-modifying enzymes, have been described which can either prevent the schistosomal infection itself or can check it from reaching an advanced stage.
Conclusions
Epidemiological, clinical, pathological and surgical studies suggest that Schistosoma japonicum is responsible for induction of colorectal cancer. However, thorough clinical studies are required to support and globally accept this notion. Further, methodologies highlighted in this work can be employed in order to take care of schistosomal infection or address the cancer induction and progression.
Similar content being viewed by others
Data Availability
Data sharing is not applicable to this article as no datasets were generated in the current review.
References
Cooper GM, Hausman RE (2007) The cell-a molecular approach. Sinauer Associates, USA: Sunderland
Lodish H, Berk A, Zipursky SL, Matsudira P, Baltimore D, Darnell JE (2003) Molecular cell biology, 5th edn. W. H. Freeman, New York
Owen JA, Punt J, Stranford SA (2013) Kuby immunology, 7th edn. Susan, Winslow
Jain S, Sengupta M, Jain P (2019) Non-viral parasites associated with carcinogenesis. Cancer Invest 37(9):453–462. https://doi.org/10.1080/07357907.2019.1662918
Machicado C, Marcos LA (2016) Carcinogenesis associated with parasites other than Schistosoma, Opisthorchis and Clonorchis: a systematic review. Int J Cancer 138(12):2915–2921. https://doi.org/10.1002/ijc.30028
Khaled H (2013) Schistosomiasis and cancer in Egypt: review. J Adv Res 4(5):461–466. https://doi.org/10.1016/j.jare.2013.06.007
Bacelar A, Castro LG, de Queiroz AC, Café E (2007) Association between prostate cancer and schistosomiasis in young patients: a case report and literature review. Braz J Infect Dis 11(5):520–522. https://doi.org/10.1590/s1413-86702007000500014
Figueiredo JC, Richter J, Borja N, Balaca A, Costa S, Belo S, Grácio MA (2015) Prostate adenocarcinoma associated with prostatic infection due to schistosoma haematobium case report and systematic review. Parasitol Res 114(2):351–358. https://doi.org/10.1007/s00436-014-4250-9
Hamid H (2019) Schistosoma japonicum-associated colorectal cancer: a review. Am J Trop Med 100(3):501–505. https://doi.org/10.4269/ajtmh.18-0807
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–E386. https://doi.org/10.1002/ijc.29210
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J 71(3):209–249. https://doi.org/10.3322/caac.21660
Colley DG, Bustinduy AL, Secor WE, King CH (2014) Human schistosomiasis. Lancet 383(9936):2253–2264. https://doi.org/10.1016/S0140-6736(13)61949-2
Roberts L, Janovy J, Nadler S (2012) Foundations of parasitology. McGraw-Hill education, US
Rudge JW, Carabin H, Balolong E, Tallo V, Shrivastava J, Lu DB, Basáñez MG, Olveda R, McGarvey ST, Webster JP (2008) Population genetics of Schistosoma japonicum within the Philippines suggest high levels of transmission between humans and dogs. PLoS Negl Trop Dis 2(11):e340. https://doi.org/10.1371/journal.pntd.0000340
McManus DP, Dunne DW, Sacko M, Utzinger J, Zhou VBJ, XN, (2018) Schistosomiasis. Nat Rev Dis Primers 4(1):13. https://doi.org/10.1038/s41572-018-0013-8
Deslyper G, Doherty DG, Carolan JC, Holland CV (2019) The role of the liver in the migration of parasites of global significance. Parasit Vectors 12(1):531. https://doi.org/10.1186/s13071-019-3791-2
Honeycutt J, Hammam O, Hsieh MH (2015) Schistosoma haematobium egg-induced bladder urothelial abnormalities dependent on p53 are modulated by host sex. Exp Parasitol 158:55–60. https://doi.org/10.1016/j.exppara.2015.07.002
Soares Magalhães RJ, Salamat MS, Leonardo L, Gray DJ, Carabin H, McManus HK, DP, Williams GM, Rivera P, Saniel O, Hernandez L, Yakob L, McGarvey S, Clements A, (2014) Geographical distribution of human Schistosoma japonicum infection in the Philippines: tools to support disease control and further elimination. Int J Parasitol 44(13):977–984. https://doi.org/10.1016/j.ijpara.2014.06.010
Bajracharya D, Pandit S, Bhandari D (2020) First case report of schistosoma japonicum in Nepal. Access Microbiol 2(6):acmi000117
Xu Z, Su DL (1984) Schistosoma japonicum and colorectal cancer: an epidemiological study in the People’s Republic of China. Int J Cancer 34(3):315–318. https://doi.org/10.1002/ijc.2910340305
Guo W, Zheng W, Li JY, Chen JS, Blot WJ (1993) Correlations of colon cancer mortality with dietary factors, serum markers, and schistosomiasis in China. Nutr Cancer 20(1):13–20. https://doi.org/10.1080/01635589309514266
Zhang R, Takahashi S, Orita S, Yoshida A, Maruyama H, Shirai T, Ohta N (1998) p53 gene mutations in rectal cancer associated with schistosomiasis japonica in chinese patients. Cancer Lett 131(2):215–221. https://doi.org/10.1016/s0304-3835(98)00154-2
Matsuda K, Masaki T, Ishii S, Yamashita H, Watanabe T, Nagawa H, Muto T, Hirata Y, Kimura K, Kojima S (1999) Possible associations of rectal carcinoma with Schistosoma japonicum infection and membranous nephropathy: a case report with a review. Jpn J Clin Oncol 29(11):576–581. https://doi.org/10.1093/jjco/29.11.576
Qiu DC, Hubbard AE, Zhong B, Zhang Y, Spear RC (2005) A matched, case-control study of the association between Schistosoma japonicum and liver and colon cancers, in rural China. Ann Trop Med Parasitol 99(1):47–52. https://doi.org/10.1179/136485905X19883
Ye C, Tan S, Jiang L (2013) Endoscopic characteristics and causes of misdiagnosis of intestinal schistosomiasis. Mol Med Rep 8:1089–1093. https://doi.org/10.3892/mmr.2013.1648
Almoghrabi A, Mzaik O, Attar B (2021) Schistosoma japonicum associated with colorectal cancer. ACG Case Rep J 8(5):e00572. https://doi.org/10.14309/crj.0000000000000572
CDC: https://www.cdc.gov/parasites/schistosomiasis/index.html. Accessed 25 July 2023
Gryseels B (2012) Schistosomiasis. Infect Dis Clin N Am 26(2):383–397. https://doi.org/10.1016/j.idc.2012.03.004
Wong MC, Ding H, Wang J, Chan PS, Huang J (2019) Prevalence and risk factors of colorectal cancer in Asia. Intest Res 17(3):317–329. https://doi.org/10.5217/ir.2019.00021
Cheng Y, Ling Z, Li L (2020) The intestinal microbiota and colorectal cancer. Front Immunol 11:615056. https://doi.org/10.3389/fimmu.2020.615056
Sánchez-Alcoholado L, Ramos-Molina B, Otero A, Laborda-Illanes A, Ordóñez R, Medina JA, Gómez-Millán J, Queipo-Ortuño MI (2020) The role of the gut microbiome in colorectal cancer development and therapy response. Cancers 12(6):1406. https://doi.org/10.3390/cancers12061406
Phipps AI, Passarelli MN, Chan AT, Harrison TA, Jeon J, Hutter CM, Berndt SI, Brenner H, Caan BJ, Campbell PT, Chang-Claude J, Chanock SJ, Cheadle JP, Curtis KR, Duggan D, Fisher D, Fuchs CS, Gala M, Giovannucci EL, Hayes RB et al (2016) Common genetic variation and survival after colorectal cancer diagnosis: a genome-wide analysis. Carcinogenesis 37(1):87–95. https://doi.org/10.1093/carcin/bgv161
Djursby M, Madsen MB, Frederiksen JH, Berchtold LA, Therkildsen C, Willemoe GL, Hasselby JP, Wikman F, Okkels H, Skytte AB, Nilbert M, Wadt K, Gerdes AM, van Overeem HT (2020) New pathogenic germline variants in very early onset and familial colorectal cancer patients. Front Genet 11:566266. https://doi.org/10.3389/fgene.2020.566266
He Y, Timofeeva M, Li X, Din F, Blackmur JP, Vaughan-Shaw P, Svinti V, Farrington SM, Campbell H, Dunlop MG, Theodoratou E (2019) A comprehensive study of the effect on colorectal cancer survival of common germline genetic variation previously linked with cancer prognosis. Cancer Epidemiol Biomark Prev 28(11):1944–1946. https://doi.org/10.1158/1055-9965.EPI-19-0596
Song N, Lee J, Cho S, Kim J, Oh J, Shin A (2019) Evaluation of gene-environment interactions for colorectal cancer susceptibility loci using case-only and case-control designs. BMC Cancer. https://doi.org/10.1186/s12885-019-6456-9
Yang T, Li X, Montazeri Z, Little J, Farrington SM, Ioannidis J, Dunlop MG, Campbell H, Timofeeva M, Theodoratou E (2019) Gene-environment interactions and colorectal cancer risk: an umbrella review of systematic reviews and meta-analyses of observational studies. Int J Cancer 145(9):2315–2329. https://doi.org/10.1002/ijc.32057
Rosin MP, Anwar WA, Ward AJ (1994) Inflammation, chromosomal instability, and cancer: the schistosomiasis model. Cancer Res 54(7):1929s–1933s
Ishii A, Matsuoka H, Aji T, Ohta N, Arimoto S, Wataya Y, Hayatsu H (1994) Parasite infection and cancer: with special emphasis on Schistosoma japonicum infections (Trematoda): a review. Mutat Res 305(2):273–281. https://doi.org/10.1016/0027-5107(94)90247-x
Ishii A, Matsuoka H, Aji T, Hayatsu H, Wataya Y, Arimoto S, Tokuda H (1989) Evaluation of the mutagenicity and the tumor-promoting activity of parasite extracts: Schistosoma japonicum and Clonorchis sinensis. Mutat Res 224(2):229–233. https://doi.org/10.1016/0165-1218(89)90160-2
van Tong H, Brindley PJ, Meyer CG, Velavan TP (2017) Parasite infection, carcinogenesis and human malignancy. EBioMedicine 15:12–23. https://doi.org/10.1016/j.ebiom.2016.11.034
Herrera LA, Benítez-Bribiesca L, Mohar A, Ostrosky-Wegman P (2005) Role of infectious diseases in human carcinogenesis. Environ Mol Mutagen 45(2–3):284–303. https://doi.org/10.1002/em.20122
Ambs S, Bennett WP, Merriam WG, Ogunfusika MO, Oser SM, Harrington AM, Shields PG, Felley-Bosco E, Hussain SP, Harris CC (1999) Relationship between p53 mutations and inducible nitric oxide synthase expression in human colorectal cancer. J Natl Cancer Inst 91(1):86–88. https://doi.org/10.1093/jnci/91.1.86
Cianchi F, Cortesini C, Fantappiè O, Messerini L, Schiavone N, Vannacci A, Nistri S, Sardi I, Baroni G, Marzocca C, Perna F, Mazzanti R, Bechi P, Masini E (2003) Inducible nitric oxide synthase expression in human colorectal cancer: correlation with tumor angiogenesis. Am J Pathol 162(3):793–801. https://doi.org/10.1016/S0002-9440(10)63876-X
Long XC, Bahgat M, Chlichlia K, Ruppel A, Li YL (2004) Detection of inducible nitric oxide synthase in Schistosoma japonicum and S. mansoni. J Helminthol 78(1):47–50. https://doi.org/10.1079/joh2003202
Wu C, Du X, Tang L, Wu J, Zhao W, Guo X, Liu D, Hu W, Helmby H, Chen G, Wang Z (2020) Schistosoma japonicum SjE16.7 protein promotes tumor development via the receptor for advanced glycation end products (RAGE). Front Immunol 11:1767. https://doi.org/10.3389/fimmu.2020.01767
Weglage J, Wolters F, Hehr L, Lichtenberger J, Wulz C, Hempel F, Baier A, Quack T, Köhler K, Longerich T, Schramm G, Irungbam K, Mueller H, von Buelow V, Tschuschner A, Odenthal M, Drebber U, Arousy ME, Ramalho L, Bankov K et al (2020) Schistosoma mansoni eggs induce Wnt/β-catenin signaling and activate the protooncogene c-Jun in human and hamster colon. Sci Rep 10(1):22373. https://doi.org/10.1038/s41598-020-79450-4
Abruzzi A, Bernard Fried B (2011) Coinfection of Schistosoma (trematoda) with bacteria protozoa and helminths. Adv Parasitol. https://doi.org/10.1016/B978-0-12-391429-3.00005-8
LoVerde PT, Amento C, Higashi GI (1980) Parasite-parasite interaction of Salmonella typhimurium and Schistosoma. J Infect Dis 141:177–185. https://doi.org/10.1093/infdis/141.2.177
Tuazon CU, Nash T, Cheever A, Neva F (1985) Interaction of Schistosoma japonicum with Salmonellae and other gram-negative bacteria. J Infect Dis 152(4):722–726. https://doi.org/10.1093/infdis/152.4.722
Melhem RF, LoVerde PT (1984) Mechanism of interaction of Salmonella and Schistosoma species. Infect Immun 44(2):274–281. https://doi.org/10.1128/IAI.44.2.274-281.1984
Barnhill AE, Novozhilova E, Day TA, Carlson SA (2011) Schistosoma-associated Salmonella resist antibiotics via specific fimbrial attachments to the flatworm. Parasit Vectors 4:123. https://doi.org/10.1186/1756-3305-4-123
Caygill CPJ, Braddick M, Hill MJ, Knowles RL, Sharp JCM (1995) The association between typhoid carriage, typhoid infection and subsequent cancer at a number of sites. Eur J Cancer Prev 4(2):187–194. https://doi.org/10.1097/00008469-199504000-00010
Scanu T, Spaapen RM, Bakker JM, Pratap CB, Wu LE, Hofland I, Broeks A, Shukla VK, Kumar M, Janssen H, Song JY, Neefjes-Borst EA, te Riele H, Holden DW, Nath G, Neefjes J (2015) Salmonella manipulation of host signaling pathways provokes cellular transformation associated with gallbladder carcinoma. Cell Host Microbe 17(6):763–774. https://doi.org/10.1016/j.chom.2015.05.002
Mughini-Gras L, Schaapveld M, Kramers J, Mooij S, Neefjes-Borst EA, Pelt WV, Neefjes J (2018) Increased colon cancer risk after severe Salmonella infection. PLoS ONE 13(1):e0189721
Lu R, Bosland M, Xia Y, Zhang YG, Kato I, Sun J (2017) Presence of Salmonella AvrA in colorectal tumor and its precursor lesions in mouse intestine and human specimens. Oncotarge 8(33):55104–55115
Chen MC, Hu JC, Chang PY, Chuang CY, Ts’ao PF, Chang SH, Wang FP, Ch’en TL, Chou SC (1965) Pathogenesis of carcinoma of the colon and rectum in schistosomiasis japonica: a study on 90 cases. Chin Med J 84(8):513–525
Ming-Chai C, Chi-Yuan C, Pei-Yu C, Jen-Chun H (1980) Evolution of colorectal cancer in schistsosomiasis: transitional mucosal changes adjacent to large intestinal carcinoma in colectomy specimens. Cancer 46(7):1661–1675. https://doi.org/10.1002/10970142(19801001)46:7%3c1661::aidcncr2820460728%3e3.0.co;2-o
Liu W, Zeng HZ, Wang QM (2013) Schistosomiasis combined with colorectal carcinoma diagnosed based on endoscopic findings and clinicopathological characteristics: a report on 32 cases. Asian Pac J Cancer Prev 14:4839–4842. https://doi.org/10.7314/APJCP.2013.14.8.4839
Qin X, Liu CY, Xiong YL, Bai T, Zhang L, Hou XH, Song J (2021) The clinical features of chronic intestinal schistosomiasis-related intestinal lesions. BMC gastroenterol 21(1):12. https://doi.org/10.1186/s12876-020-01591-7
Hamed MA, Ahmed SA, Khaled HM (2011) Efficiency of diagnostic biomarkers among colonic schistosomiasis egyptian patients. Mem Inst Oswaldo Cruz 106:322–329. https://doi.org/10.1590/s0074-02762011000300011
Zhang W, Wang PJ, Shen X (2012) CT presentations of colorectal cancer with chronic schistosomiasis: a comparative study with pathological findings. Eur J Radiol 81:e835-843. https://doi.org/10.1016/j.ejrad.2012.02.020
Feng H, Lu AG, Zhao XW (2015) Comparison of non-schistosomal rectosigmoid cancer and schistosomal rectosigmoid cancer. World J Gastroenterol 21:7225–7232. https://doi.org/10.3748/wjg.v21.i23.7225
Lin M, Hanai J, Gui L (1998) Peanut lectin-binding sites and mucins in benign and malignant colorectal tissues associated with schistsomiasis. Histol Histopathol 13:961–966
Wang M, Zhang YC, Yang XY, Wang ZQ (2014) Prognostic analysis of schistosomal rectal cancer. Asian Pac J Cancer Prev 15:9271–9275. https://doi.org/10.7314/apjcp.2014.15.21.9271
Lombardi L, Morelli F, Cinieri S (2010) Adjuvant colon cancer chemotherapy: where we are and where we’ll go. Cancer Treat Rev 36:S34-41. https://doi.org/10.1016/S0305-7372(10)70018-9
Ahmed S, Johnson K, Ahmed O (2014) Advances in the management of colorectal cancer: from biology to treatment. Int J Colorectal Dis 29:1031–1042. https://doi.org/10.1007/s00384-014-1928-5
Yi Z, Hong-Gang J, Zhi-Heng C (2016) Short-term efficacy of laparoscopic treatment for colorectal cancer in patients with Schistosomiasis japonica. Gastroenterol Res Pract 2016:8357025. https://doi.org/10.1155/2016/8357025
Chen MG (2014) Assessment of morbidity due to Schistosoma japonicum infection in China. Infect Dis Poverty 3(1):6. https://doi.org/10.1186/2049-9957-3-6
Wang M, Wu QB, He WB, Wang ZQ (2016) Clinicopathological characteristics and prognosis of schistosomal colorectal cancer. Colorectal Dis 18:1005–1009. https://doi.org/10.1111/codi.13317
Sauer R, Becker H, Hohenberger W (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731–1740. https://doi.org/10.1056/NEJMoa040694
Zhang Y, Chen Z, Li J (2017) The current status of treatment for colorectal cancer in China: a systematic review. Medicine (Baltimore). https://doi.org/10.1097/MD.0000000000008242
Abdelkareem EA, Sharief AH, Huat LB (2014) Identification of specific proteins in colorectal cancer patients with Schistosoma mansoni infection as a possible biomarker for the treatment of this infection. Asian Pac J Trop Dis 4:S720–S724. https://doi.org/10.1016/S2222-1808(14)60714-3
Li Y, Chen D, Ross AG (2011) Severe hepatosplenic schistosomiasis: clinicopathologic study of 102 cases undergoing splenectomy. Hum Pathol 42:111–119. https://doi.org/10.1016/j.humpath.2010.05.020
Abruzzi A, Fried B, Alikhan SB (2016) Coinfection of Schistosoma species with Hepatitis B or Hepatitis C viruses. Adv Parasitol 91:111–231. https://doi.org/10.1016/bs.apar.2015.12.003
Rubbia-Brandt L, Audard V, Sartoretti P (2004) Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 15:460–466. https://doi.org/10.1093/annonc/mdh095
Madbouly KM, Hussein AM, Zeid A (2013) Colorectal cancer surgery in portal hypertensive patients: does adjuvant oxaliplatin affect prognosis? Dis Colon Rectum 56:577–585. https://doi.org/10.1097/DCR.0b013e318286f8fc
Prat A, Casado E, Cortés J (2007) New approaches in angiogenic targeting for colorectal cancer. World J Gastroenterol 13(44):5857–5866. https://doi.org/10.3748/wjg.v13.i44.5857
Jain S, Kumar S (2020) Cancer immunotherapy: dawn of the death of cancer? Int Rev Immunol 12:1–18. https://doi.org/10.1080/08830185.2020.1775827
Veenstra CM, Krauss JC (2018) Emerging systemic therapies for colorectal cancer. Clin Colon Rectal Surg 31:179–191. https://doi.org/10.1055/s-0037-1602238
Salim EI, Morimura K, Menesi A (2008) Elevated oxidative stress and DNA damage and repair levels in urinary bladder carcinomas associated with schistosomiasis. Int J Cancer 123:601–608. https://doi.org/10.1002/ijc.23547
Motallebnezhad M, Jadidi-Niaragh F, Qamsari ES (2016) The immunobiology of myeloid-derived suppressor cells in cancer. Tumour Biol 37:1387–1406. https://doi.org/10.1007/s13277-015-4477-9
Van Herk EH, Te Velde AA (2016) Treg subsets in inflammatory bowel disease and colorectal carcinoma: characteristics, role, and therapeutic targets. J Gastroenterol Hepatol 31:1393–1404
Wang Z, Du Z, Liu Y, Wang W, Liang M, Zhang A, Yang J (2020) Comparison of the clinicopathological features and prognoses of patients with schistosomal and nonschistosomal colorectal cancer. Oncol Lett 19:2375–2383. https://doi.org/10.3892/ol.2020.11331
Wang Z, Du Z, Sheng H, Xu X, Wang W, Yang J, Sun J, Yang J (2021) Polarization of intestinal tumour-associated macrophages regulates the development of schistosomal colorectal cancer. J Cancer 12(4):1033–1041. https://doi.org/10.7150/jca.48985
Pan W, Wang W, Huang J, Lu K, Huang S, Jiang D, Bu D, Liu J, Jing H, Yao J, Hou Y (2020) The prognostic role of c-MYC amplification in schistosomiasis-associated colorectal cancer. Jpn J Clin Oncol 50(4):446–455. https://doi.org/10.1093/jjco/hyz210
Inobaya MT, Olveda RM, Chau TN, Olveda DU (2014) Ross AG (2014) prevention and control of schistosomiasis: a current perspective. Res Rep Trop Med 5:65–75. https://doi.org/10.2147/RRTM.S44274
Secor EW (2014) Water-based interventions for schistosomiasis control. Pathog Glob Health 108(5):246–254. https://doi.org/10.1179/2047773214Y.0000000149
Osakunor DNM, Woolhouse MEJ, Mutapi F (2018) Paediatric schistosomiasis: what we know and what we need to know. PLoS Negl Trop Dis 12(2):e0006144
Campbell SJ, Biritwum NK, Woods G, Velleman Y, Fleming F, Stothard JR (2018) Tailoring water, sanitation, and hygiene (wash) targets for soil-transmitted helminthiasis and schistosomiasis control. Trends Parasitol 34(1):53–63. https://doi.org/10.1016/j.pt.2017.09.004
Molehin AJ (2020) Schistosomiasis vaccine development: update on human clinical trials. J Biomed Sci 27(1):28. https://doi.org/10.1186/s12929-020-0621-y
Gouveia MJ, Brindley PJ, Gärtner F, Costa JMCD, Vale N (2018) Drug repurposing for schistosomiasis: combinations of drugs or biomolecules. Pharmaceuticals (Basel). https://doi.org/10.3390/ph11010015
Xiao SH, Mei JY, Jiao PY (2011) Effect of mefloquine administered orally at single, multiple, or combined with artemether, artesunate, or praziquantel in treatment of mice infected with Schistosoma japonicum. Parasitol Res 108(2):399–406. https://doi.org/10.1007/s00436-010-2080-y
El Kouni MH, Knopf PM, Cha SM (1985) Combination therapy of Schistosoma japonicum by tubercidin and nitrobenzylthioinosine 5′-monophosphate. Biochem Pharmacol 34(21):3921–3923. https://doi.org/10.1016/0006-2952(85)90445-9
Gray DJ, Ross AG, Li YS, McManus DP (2011) Diagnosis and management of schistosomiasis. BMJ. https://doi.org/10.1136/bmj.d2651
Giam M, Huang DC, Bouillet P (2008) BH3-only proteins and their roles in programmed cell death. Oncogene 27(1):S128-136. https://doi.org/10.1038/onc.2009.50
Lee EF, Young ND, Lim NT, Gasser RB, Fairlie WD (2014) Apoptosis in schistosomes: toward novel targets for the treatment of schistosomiasis. Trends Parasitol 30(2):75–84. https://doi.org/10.1016/j.pt.2013.12.005
Pierce RJ, Dubois-Abdesselem F, Caby S, Trolet J, Lancelot J, Oger F, Bertheaume N, Roger E (2011) Chromatin regulation in schistosomes and histone modifying enzymes as drug targets. Mem Inst Oswaldo Cruz 106(7):794–801. https://doi.org/10.1590/s0074-02762011000700003
Pierce RJ, Dubois-Abdesselem F, Lancelot J, Andrade L, Oliveira G (2012) Targeting schistosome histone modifying enzymes for drug development. Curr Pharm Des 18(24):3567–3578
Ramirez BL, Kurtis JD, Wiest PM, Arias P, Aligui F, Acosta L, Peters P, Olds GR (1996) Paramyosin: a candidate vaccine antigen against Schistosoma japonicum. Parasite Immunol 18(1):49–52
Jiz M, Wu H, Meng R, Pond-Tor S, Reynolds M, Friedman JF, Olveda R, Acosta L, Kurtis JD (2008) Pilot-scale production and characterization of paramyosin, a vaccine candidate for schistosomiasis japonica. Infect Immun 76(7):3164–3169. https://doi.org/10.1128/IAI.00409-08
Jiz MA, Wu H, Olveda R, Jarilla B, Kurtis JD (2015) Development of paramyosin as a vaccine candidate for Schistosomiasis. Front Immunol 6:347. https://doi.org/10.3389/fimmu.2015.00347
Tiu WU, Davern KM, Wright MD, Board PG, Mitchell GF (1988) Molecular and serological characteristics of the glutathione S-transferases of Schistosoma japonicum and Schistosoma mansoni. Parasite Immunol 10(6):693–706. https://doi.org/10.1111/j.1365-3024.1988.tb00255.x
Wei F, Liu Q, Gao S, Shang L, Zhai Y, Men J, Jiang L, Zhu XQ, Fu Z, Shi Y, Xia Z, Lin J (2008) Enhancement by IL-18 of the protective effect of a Schistosoma japonicum 26kDa GST plasmid DNA vaccine in mice. Vaccine 26(33):4145–4149. https://doi.org/10.1016/j.vaccine.2008.05.034
You H, Gobert GN, Duke MG, Zhang W, Li Y, Jones MK (2012) The insulin receptor is a transmission blocking veterinary vaccine target for zoonotic Schistosoma japonicum. Int J Parasitol 42(9):801–807. https://doi.org/10.1016/j.ijpara.2012.06.002
Tebeje BM, Harvie M, You H, Loukas A, McManus DP (2016) Schistosomiasis vaccines: where do we stand? Parasit Vectors 9(1):528. https://doi.org/10.1186/s13071-016-1799-4
Funding
No funding source.
Author information
Authors and Affiliations
Contributions
Conceptualization of idea: SJ; data collection: SJ, MR, PC, and SK; drafting: SJ, MR, and SK; figures: SJ and MR; review and critical analysis: SJ, MR, PC, and SK.
Corresponding author
Ethics declarations
Conflict of Interest
None declared.
Ethics Approval
Not applicable.
Patient Consent
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Jain, S., Rana, M., Choubey, P. et al. Schistosoma japonicum Associated Colorectal Cancer and Its Management. Acta Parasit. 68, 723–734 (2023). https://doi.org/10.1007/s11686-023-00707-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11686-023-00707-9